Clinical trials for Ependymoblastoma
2 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT03363373Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone MarrowY-mAbs Therapeutics
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT01757626Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk NeuroblastomaMemorial Sloan Kettering Cancer Center · PI: Brian Kushner, MD